Clinical Trial Update: This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation. [Phase 1]

View source ↗

Summary

A completed Phase 1 study evaluating the safety and tolerability of multiple oral doses of an investigational drug in adults with narcolepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• Investigational oral drug for narcolepsy

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Narcolepsy | Phase 1 | Status: COMPLETED